^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Tysabri (natalizumab)

i
Other names: AN100226, AN 100226, BG00002, BG-0002, AN-10022, BG-00002, BG-0002-E
Associations
Trials
Company:
Biogen, Royalty
Drug class:
α4β1 integrin antagonist, α4β7 integrin antagonist
Associations
Trials